TABLE 3.
Changes in Secondary outcomes in both groups.
Outcomes | Experimental group (n = 25) | Control group (n = 23) | ||||
---|---|---|---|---|---|---|
Baseline | After 4 weeks | P/t value | Baseline | After 4 weeks | P/t value | |
FMA-UE | 16.44 ± 11.72 | 25.20 ± 14.03 | <0.001/5.435 | 16.22 ± 11.66 | 20.61 ± 12.10 | <0.001/5.633 |
FMA-LE | 18.80 ± 6.34 | 25.16 ± 472 | <0.001/5.120 | 17.70 ± 7.36 | 22.91 ± 5.91 | <0.001/4.816 |
BBS | 21.84 ± 14.38 | 40.56 ± 11.42 | <0.001/6.378 | 24.52 ± 18.90 | 30.87 ± 16.57 | <0.001/5.674 |
BI | 59.20 ± 17.18 | 86.20 ± 14.24 | <0.001/8.332 | 61.96 ± 21.94 | 71.30 ± 17.85 | <0.001/6.951 |